MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹3.66 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr | ₹7.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹3.66 Cr |
Mar2024 | ₹11 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹7.26 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3.66 Cr | -65.52 | |
Mar2024 | ₹11 Cr | -30.98 | |
Mar2023 | ₹15 Cr | 11.78 | |
Mar2022 | ₹14 Cr | 89.48 | |
Mar2021 | ₹7.26 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,588.3 Cr | -2% | 3.3% | 37.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -2% |
3.3% |
37.9% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses